Timeslots are filling quickly, apply today!

4C Medical Logo.jpg

4C Medical Technologies (Brooklyn Park, MN) is focused on minimally invasive therapies for structural heart disease, specifically mitral valve regurgitation.

AiM_logocolor copy.jpg

AiM Medical Robotics (Fort Lauderdale, FL) is developing an MRI compatible surgical robotic system for advanced neurosurgical procedures. MRI compatibility allows the robotic system to provide real time image guidance and automated precision movements. Our robotic system will drive better outcomes in a less invasive and more timely fashion than existing operating systems.


BioAesthetics (Research Triangle Park, NC) is transforming lives through advancements in biomaterials. The company has developed NACgraft - an acellular biologic graft for regeneration of the nipple-areolar complex (NAC) for breast cancer-related mastectomy patients.

Copy of embody logo 2017 cmyk-01 - Jeff Conroy.jpg

Embody LLC (Norfold, VA) is a medical device company developing collagen-based implants for the treatment of tendon and ligament injuries. With $12 million in funding from DARPA, Embody will launch our Tapestry Achilles implant in 2019 following FDA 510(k) clearance. In 2020, we will launch the first collagen internal brace and a Tapestry Rotator Cuff Implant. We have over $6 million in guaranteed, non-dilutive funding going forward, so our investors are funding commercial launch and revenue generation.

Gel-e Life Sciences.jpg

gel-e (College Park, MD) is a clinical-stage medical device company developing versatile hemostatic products for surgical, medical, and consumer applications. gel-e combines the use of safe, inert ingredients with proprietary chemistry across a broad spectrum of clinical applications. The company has raised over $9M through private equity and grant funding for the commercial launchpad for multiple gel-e products. gel-e has been featured on the BBC’s “Brave New World” with Stephen Hawking based on 3 FDA Clearances, 7 issued patents and 7 peer-reviewed publications.

LM-LOGO-HORZ-COL - Vance Clement.jpg

Lineus Medical (Fayetteville, AR) Patients in the hospital dislodge their IVs 11% of the time, according to clinical literature. Lineus Medical is the developer of SafeBreak, a break away medical device that fits in any IV line and prevents IV dislodgement by separating into two pieces. When the device separates, valves on both sides of the device stop the flow of fluids and cause the IV pump to alarm. SafeBreak can be easily and quickly replaced, the IV restarted, and without re-sticking the patient.


Nutrimedy (Brookline, MA) is a HIPAA compliant web and mobile platform that connects users to Registered Dietitians for expert nutrition support at their fingertips. We provide more meaningful, longitudinal support through built-in video appointments, secure messaging, file sharing, educational content, customizable trackers, and photo food logging. Nutrimedy can work with medical device companies to deliver nutrition support to patients who receive their devices. In this arrangement, a specific device may be related to a condition in which nutrition plays an important role.

RxFunction Logo.png

RxFunction (Minnetonka, MN) is a start-up medical device company focused on designing and bringing to market medical technologies that restore balance, increase mobility, and enhance confidence. Our first product is Walkasins, a one-of-a-kind, non-invasive sensory neuroprosthesis that improves balance for people with sensory peripheral neuropathy at risk of falling. RxFunction is privately held and headquartered in Eden Prairie. Walkasins is manufactured in Minnesota, has not been submitted to the FDA for review, and is not yet available for sale in the U.S.


SentiAR (St. Louis, MO) is developing the first application of Mixed Reality technology for use during cardiac ablation procedures, including the treatment of atrial fibrillation. The SentiAR platform provides an immersive command-center for the clinicians by presenting a 3D hologram of the patient’s electroanatomic data via the Microsoft HoloLens in real-time. Our solution gives the clinician unprecedented control via SentiAR’s patent protected, intuitive gaze interface and provides invaluable insight to guide physician diagnosis and catheter placement.

stelect_Primary (1) - Elise Sutherland.png

Stelect (Melbourne, Australia) is an Australian based medical device company developing a novel coronary imaging balloon catheter. The imaging capabilities provides an inside-out view of the artery, allowing for accurate blockage dimensioning and characterisation. By integrating with a balloon catheter, Stelect minimises the disruption to current procedural workflow and allows for greater reimbursement. The novelty of the Stelect device lies within Stelect’s sensors themselves, the smallest commercially available sensors for intravascular imaging and our ability to integrate these sensors onto existing catheters.

wise_payoff - Sara Rebasti.png

Wise SRL (Milan, Italy) is developing a genuinely new generation of Neuromonitoring and Neuromodulation electrodes by means of its proprietary SCBI technology. WISE’s electrodes are highly ergonomic, conformable, soft and thin, thus allowing great adhesion, minimal invasiveness and excellent adaptability on neural tissues. Currently, WISE is clinically validating its WCS electrodes for electrophysiological brain monitoring and completing the development of the WISE ExPert lead, the first multi-column SCS paddle lead that can be implanted percutaneously by a pain therapist.

Zepto Envelope Logo - Jenn Juillard.jpg

Zepto Life Technology (St. Paul, MN) is building an immunoassay and molecular POC platform with Lab-On-A-Chip technology that boasts high-sensitivity and high-specificity, providing the most accurate and timely clinical diagnostic testing at the point of need.